ADC Therapeutics scores FDA approval for anti-CD19 blood cancer med Zynlonta April 23, 2021 Auto Bot News 0 ADC Therapeutics scores FDA approval for anti-CD19 blood cancer med Zynlonta esagonowsky Fri, 04/23/2021 – 16:06
